Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age

  • End date
    Dec 13, 2022
  • participants needed
  • sponsor
    Tulika Singh, MD
Updated on 13 December 2021


To assess patient reported treatment satisfaction and medication tolerability in virologically suppressed HIV-1 infected adults who are at least 65 years of age who switch to a bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) fixed-dose combination regimen.

Condition HIV-1-infection
Treatment B/F/TAF
Clinical Study IdentifierNCT05147740
SponsorTulika Singh, MD
Last Modified on13 December 2021


Yes No Not Sure

Inclusion Criteria

Be at least 65 years of age at the time of signing the informed consent form
Be currently receiving an antiretroviral regimen for ≥ 3 months prior to the screening visit
Have documented plasma HIV-1 RNA < 50 copies/mL for a minimum of 3 months on current ART regimen
Have a plasma HIV-1 RNA < 50 copies/mL at screening visit

Exclusion Criteria

Have resistance to tenofovir (K65R/E/N, ≥3 thymidine analogue mutations or T69-insertions), primary INSTI-resistance, or a history of failure on an INSTI-based regimen
Have been treated with B/F/TAF
Participants with CrCl <30 mL/min
Known or suspected severe hepatic impairment (Child-Pugh Class C)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note